Find a Provider

Tara C. Gangadhar, MD

Tara C. Gangadhar, MD Physician

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Gangadhar is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Medical Oncology

Programs & Services:

  • Cancer
    • Merkel Cell Carcinoma
    • Skin Cancer

Board Certification:

  • Internal Medicine, 2007
  • Medical Oncology, 2010

Conditions & Treatments:

  • Cancer Clinical Trials
  • malignant melanoma
  • melanoma
  • Melanoma
  • Non-Melanoma Skin Cancer
  • Skin Cancer
  • skin melanoma

Clinical Interests

Melanoma
Cutaneous malignancies
Gastroinitestinal malignancies

Practice Locations and Appointments

  • Melanoma and Pigmented Lesions

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-PENN (7366)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: New York University School of Medicine
Residency: Indiana University Hospital
Fellowship: University of Chicago Medical Center

Memberships

Abramson Cancer Center of the University of Pennsylvania, National American Society of Clinical Oncology, National American Society of Clinical Pharmacology and Therapeutics, National Melanoma Research Foundation Breakthrough Consortium, National Penn Institute for Immunolology, Local Society for Melanoma Research, International

Affiliation

Dr. Gangadhar is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Research Interests:

Melanoma
Immune therpay
Targeted therapy
Phase I trials
Combination therapy
Experimental therapeutics
Pharmacology

Selected Publications:

Twyman-Saint Victor Christina, Rech Andrew J, Maity Amit, Rengan Ramesh, Pauken Kristen E, Stelekati Erietta, Benci Joseph L, Xu Bihui, Dada Hannah, Odorizzi Pamela M, Herati Ramin S, Mansfield Kathleen D, Patsch Dana, Amaravadi Ravi K, Schuchter Lynn M, Ishwaran Hemant, Mick Rosemarie, Pryma Daniel A, Xu Xiaowei, Feldman Michael D, Gangadhar Tara C, Hahn Stephen M, Wherry E John, Vonderheide Robert H, Minn Andy J: Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520 (7547): 373-7,2015.

Wang Tao, Xiao Min, Ge Yingbin, Krepler Clemens, Belser Eric, Lopez-Coral Alfonso, Xu Xiaowei, Zhang Gao, Azuma Rikka, Liu Qin, Liu Rui, Li Ling, Amaravadi Ravi K, Xu Wei, Karakousis Giorgos, Gangadhar Tara C, Schuchter Lynn M, Lieu Melissa, Khare Sanika, Halloran Molly B, Herlyn Meenhard, Kaufman Russel E: BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth. Clinical cancer research : an official journal of the American Association for Cancer Research 21 (7): 1652-64,2015.

Robert Caroline, Ribas Antoni, Wolchok Jedd D, Hodi F Stephen, Hamid Omid, Kefford Richard, Weber Jeffrey S, Joshua Anthony M, Hwu Wen-Jen, Gangadhar Tara C, Patnaik Amita, Dronca Roxana, Zarour Hassane, Joseph Richard W, Boasberg Peter, Chmielowski Bartosz, Mateus Christine, Postow Michael A, Gergich Kevin, Elassaiss-Schaap Jeroen, Li Xiaoyun Nicole, Iannone Robert, Ebbinghaus Scot W, Kang S Peter, Daud Adil: Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet 384 (9948): 1109-17,2014.

Braunstein Inbal, Gangadhar Tara C, Elenitsas Rosalie, Chu Emily Y: Vemurafenib-induced interface dermatitis manifesting as radiation-recall and a keratosis pilaris-like eruption. Journal of Cutaneous Pathology : 2014.

Gangadhar Tara C, Vonderheide Robert H: Mitigating the toxic effects of anticancer immunotherapy. Nature Reviews Clinical Oncology 11 (2): 91-9,2014.

Tara C Gangadhar, Fecher LA, Miller C, Karakousis G, Vonderheide R, Xu G, and Schuchter LM: Melanoma Abeloff’s Clinical Oncology 5th Edition : 2014.

Hamid Omid, Robert Caroline, Daud Adil, Hodi F Stephen, Hwu Wen-Jen, Kefford Richard, Wolchok Jedd D, Hersey Peter, Joseph Richard W, Weber Jeffrey S, Dronca Roxana, Gangadhar Tara C, Patnaik Amita, Zarour Hassane, Joshua Anthony M, Gergich Kevin, Elassaiss-Schaap Jeroen, Algazi Alain, Mateus Christine, Boasberg Peter, Tumeh Paul C, Chmielowski Bartosz, Ebbinghaus Scot W, Li Xiaoyun Nicole, Kang S Peter, Ribas Antoni: Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. The New England Journal of Medicine 369 (2): 134-44,2013.

Gangadhar Tara C, Clark Joseph I, Karrison Theodore, Gajewski Thomas F: Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma. Investigational New Drugs 31 (3): 769-73,2013.

Tara C Gangadhar and Lynn M Schuchter: Adjuvant Therapy for Melanoma Melanoma 3 (3): 471-484,2012.

Sattler Martin, Reddy Mamatha M, Hasina Rifat, Gangadhar Tara, Salgia Ravi: The role of the c-Met pathway in lung cancer and the potential for targeted therapy. Therapeutic advances in medical oncology 3 (4): 171-84,2011.

View all publications

Academic Contact Info

3400 Civic Center Blvd.
South Pavilion, 7th Floor

Philadelphia, PA 19104
Phone: (215) 662-7907
Fax: (215) 662-4646
Patient appointments: 800-789-PENN (7366)